Sven Wehrwein, Director at AtriCure, Inc. (ATRC), sold 5,000 shares at $37.00 ($185K) on 2025-08-22, disclosed to the SEC on 2025-08-26.
Open-market sale of $185k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2025-11-26 | $564K | — | Filing → |
| ATRC | SELL | 2025-08-21 | $180K | — | Filing → |
| SPSC | SELL | 2024-08-13 | $725K | — | Filing → |